country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

Cat. No.: HY-N11157

Copy Link Print Information

Trihexosylceramide (d18:1/24:0)

Trihexosylceramide (d18:1/24:0) is a globotriaosylceramide (Gb3) subtype with an unmodified d18:1 sphingosine moiety and a saturated C24:0 fatty acid chain, which serves as a biomarker for Fabry disease. Trihexosylceramide (d18:1/24:0) is applicable to the research of Fabry disease.

For research use only. We do not sell to patients.

CAS No.: 82005-99-0
Formula: C₆₀H₁₁₃NO₁₈
Molecular Weight:1136.55

Storage:

Please store the product under the recommended conditions in the Certificate of Analysis.

Trihexosylceramide (d18:1/24:0) Chemical Structure

CAS No.: 82005-99-0

Size

Price

Stock

Quantity

Amount: USD 0.00

* Please select Quantity before adding items.

Top Publications Citing

Use of MCE Products

Fluorescent Dye

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Biological Activity
- Description
- In Vitro
Chemical Information
Purity & Documentation
References
Calculators
Help & FAQs
Classifications
Bioz

Biological Activity

Description

All Endogenous Metabolite Isoforms :

In Vitro

Trihexosylceramide (d18:1/24:0) is a globotriaosylceramide (Gb3) subtype with an unmodified d18:1 sphingosine moiety and a saturated C24:0 fatty acid chain, and serves as a biomarker for Fabry disease^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Chemical Information

CAS No. 82005-99-0
Molecular Weight 1136.55
Formula C₆₀H₁₁₃NO₁₈
SMILES

O([C@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@@H](CO)O[C@@H](OC[C@H](NC(CCCCCCCCCCCCCCCCCCCCCCC)=O)[C@@H](/C=C/CCCCCCCCCCCCC)O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O)[C@H]3O[C@H](CO)[C@H](O)[C@H](O)[C@H]3O
Structure Classification
- Others
Initial Source
- Endogenous metabolite
Shipping

Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Purity & Documentation

Handling Instructions (2659 KB)

References

[1]. Manwaring V, et al. A metabolomic study to identify new globotriaosylceramide-related biomarkers in the plasma of Fabry disease patients. Analytical chemistry. 2013 Oct 01;85(19):9039-48. [Content Brief]

Calculators

Molarity Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Concentration Concentration

Volume Volume

Molecular Weight Molecular Weight

Dilution Calculator

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

Concentration _(start) Concentration _(start)

Volume _(start) Volume _(start)

Concentration _(final) Concentration _(final)

Volume _(final) Volume _(final)

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Keywords

MOQ

Minimum order quantity

100 mg

Get Quote In-stock

Other size

Get Quote

Amount: USD 0.00

Biological Activity
- Description
- In Vitro
Chemical Information
Purity & Documentation
References

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent:

Product Name:
CAS No.:
Species:
Purity:
Quantity:

Trihexosylceramide (d18:1/24:0)

All Endogenous Metabolite Isoforms

Biological Activity

Chemical Information

Purity & Documentation

References

Calculators

Help & FAQs

Trihexosylceramide (d18:1/24:0) Related Classifications

HY-N11157 Related Classifications